Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Anti-angiogenic Ophthalmic Agent market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Myopic Choroidal Neovascularization Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-angiogenic Ophthalmic Agent include Gilead Sciences, Inc., Eyetech Inc., Becton, Dickinson and Company, Regeneron Pharmaceuticals, Inc., Genentech, Inc., Novartis AG, Allergan plc, Bayer AG and Santen Pharmaceutical Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Anti-angiogenic ophthalmic agents act as antagonists against the vascular endothelial growth factor (VEGF). When retinal pigment cells become ischemic and dry up VEGF stimulates generation of new blood vessels by a process called neovascularization. If new blood vessels are not generated properly, leakage occurs in retina, which leads to vision loss. Angiogenesis plays an important role in chronic inflammation and fibrosis, tumor growth and vascularization of ischemic tissue.
This report aims to provide a comprehensive presentation of the global market for Anti-angiogenic Ophthalmic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-angiogenic Ophthalmic Agent. This report contains market size and forecasts of Anti-angiogenic Ophthalmic Agent in global, including the following market information:
Global Anti-angiogenic Ophthalmic Agent Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-angiogenic Ophthalmic Agent Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-angiogenic Ophthalmic Agent companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-angiogenic Ophthalmic Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-angiogenic Ophthalmic Agent Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-angiogenic Ophthalmic Agent Market Segment Percentages, by Type, 2022 (%)
Myopic Choroidal Neovascularization
Macular Edema
Diabetic Retinopathy
Macular Degeneration
Global Anti-angiogenic Ophthalmic Agent Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-angiogenic Ophthalmic Agent Market Segment Percentages, by Application, 2022 (%)
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Global Anti-angiogenic Ophthalmic Agent Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-angiogenic Ophthalmic Agent Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-angiogenic Ophthalmic Agent revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-angiogenic Ophthalmic Agent revenues share in global market, 2022 (%)
Key companies Anti-angiogenic Ophthalmic Agent sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-angiogenic Ophthalmic Agent sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences, Inc.
Eyetech Inc.
Becton, Dickinson and Company
Regeneron Pharmaceuticals, Inc.
Genentech, Inc.
Novartis AG
Allergan plc
Bayer AG
Santen Pharmaceutical Co., Ltd.
Shanghai Pharmaceuticals
Johnson & Johnson
Pfizer
Sun Pharma
Otsuka Pharmaceutical Co. Ltd
Daiichi Sankyo
ERC Labs
Medicom Health care
Implant ophthalmic products GmbH
The Geuder Group, MORCHER GmbH
Novamedika
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-angiogenic Ophthalmic Agent, market overview.
Chapter 2: Global Anti-angiogenic Ophthalmic Agent market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-angiogenic Ophthalmic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-angiogenic Ophthalmic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-angiogenic Ophthalmic Agent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Anti-angiogenic Ophthalmic Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-angiogenic Ophthalmic Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-angiogenic Ophthalmic Agent Overall Market Size
2.1 Global Anti-angiogenic Ophthalmic Agent Market Size: 2022 VS 2029
2.2 Global Anti-angiogenic Ophthalmic Agent Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-angiogenic Ophthalmic Agent Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-angiogenic Ophthalmic Agent Players in Global Market
3.2 Top Global Anti-angiogenic Ophthalmic Agent Companies Ranked by Revenue
3.3 Global Anti-angiogenic Ophthalmic Agent Revenue by Companies
3.4 Global Anti-angiogenic Ophthalmic Agent Sales by Companies
3.5 Global Anti-angiogenic Ophthalmic Agent Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-angiogenic Ophthalmic Agent Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-angiogenic Ophthalmic Agent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-angiogenic Ophthalmic Agent Players in Global Market
3.8.1 List of Global Tier 1 Anti-angiogenic Ophthalmic Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-angiogenic Ophthalmic Agent Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-angiogenic Ophthalmic Agent Market Size Markets, 2022 & 2029
4.1.2 Myopic Choroidal Neovascularization
4.1.3 Macular Edema
4.1.4 Diabetic Retinopathy
4.1.5 Macular Degeneration
4.2 By Type - Global Anti-angiogenic Ophthalmic Agent Revenue & Forecasts
4.2.1 By Type - Global Anti-angiogenic Ophthalmic Agent Revenue, 2018-2023
4.2.2 By Type - Global Anti-angiogenic Ophthalmic Agent Revenue, 2024-2029
4.2.3 By Type - Global Anti-angiogenic Ophthalmic Agent Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-angiogenic Ophthalmic Agent Sales & Forecasts
4.3.1 By Type - Global Anti-angiogenic Ophthalmic Agent Sales, 2018-2023
4.3.2 By Type - Global Anti-angiogenic Ophthalmic Agent Sales, 2024-2029
4.3.3 By Type - Global Anti-angiogenic Ophthalmic Agent Sales Market Share, 2018-2029
4.4 By Type - Global Anti-angiogenic Ophthalmic Agent Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-angiogenic Ophthalmic Agent Market Size, 2022 & 2029
5.1.2 Retail Pharmacies
5.1.3 Online Pharmacies
5.1.4 Hospital Pharmacies
5.2 By Application - Global Anti-angiogenic Ophthalmic Agent Revenue & Forecasts
5.2.1 By Application - Global Anti-angiogenic Ophthalmic Agent Revenue, 2018-2023
5.2.2 By Application - Global Anti-angiogenic Ophthalmic Agent Revenue, 2024-2029
5.2.3 By Application - Global Anti-angiogenic Ophthalmic Agent Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-angiogenic Ophthalmic Agent Sales & Forecasts
5.3.1 By Application - Global Anti-angiogenic Ophthalmic Agent Sales, 2018-2023
5.3.2 By Application - Global Anti-angiogenic Ophthalmic Agent Sales, 2024-2029
5.3.3 By Application - Global Anti-angiogenic Ophthalmic Agent Sales Market Share, 2018-2029
5.4 By Application - Global Anti-angiogenic Ophthalmic Agent Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-angiogenic Ophthalmic Agent Market Size, 2022 & 2029
6.2 By Region - Global Anti-angiogenic Ophthalmic Agent Revenue & Forecasts
6.2.1 By Region - Global Anti-angiogenic Ophthalmic Agent Revenue, 2018-2023
6.2.2 By Region - Global Anti-angiogenic Ophthalmic Agent Revenue, 2024-2029
6.2.3 By Region - Global Anti-angiogenic Ophthalmic Agent Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-angiogenic Ophthalmic Agent Sales & Forecasts
6.3.1 By Region - Global Anti-angiogenic Ophthalmic Agent Sales, 2018-2023
6.3.2 By Region - Global Anti-angiogenic Ophthalmic Agent Sales, 2024-2029
6.3.3 By Region - Global Anti-angiogenic Ophthalmic Agent Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-angiogenic Ophthalmic Agent Revenue, 2018-2029
6.4.2 By Country - North America Anti-angiogenic Ophthalmic Agent Sales, 2018-2029
6.4.3 US Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.4.4 Canada Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.4.5 Mexico Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-angiogenic Ophthalmic Agent Revenue, 2018-2029
6.5.2 By Country - Europe Anti-angiogenic Ophthalmic Agent Sales, 2018-2029
6.5.3 Germany Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.5.4 France Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.5.5 U.K. Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.5.6 Italy Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.5.7 Russia Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.5.8 Nordic Countries Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.5.9 Benelux Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-angiogenic Ophthalmic Agent Revenue, 2018-2029
6.6.2 By Region - Asia Anti-angiogenic Ophthalmic Agent Sales, 2018-2029
6.6.3 China Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.6.4 Japan Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.6.5 South Korea Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.6.6 Southeast Asia Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.6.7 India Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-angiogenic Ophthalmic Agent Revenue, 2018-2029
6.7.2 By Country - South America Anti-angiogenic Ophthalmic Agent Sales, 2018-2029
6.7.3 Brazil Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.7.4 Argentina Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-angiogenic Ophthalmic Agent Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-angiogenic Ophthalmic Agent Sales, 2018-2029
6.8.3 Turkey Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.8.4 Israel Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
6.8.6 UAE Anti-angiogenic Ophthalmic Agent Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Gilead Sciences, Inc.
7.1.1 Gilead Sciences, Inc. Company Summary
7.1.2 Gilead Sciences, Inc. Business Overview
7.1.3 Gilead Sciences, Inc. Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.1.4 Gilead Sciences, Inc. Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.1.5 Gilead Sciences, Inc. Key News & Latest Developments
7.2 Eyetech Inc.
7.2.1 Eyetech Inc. Company Summary
7.2.2 Eyetech Inc. Business Overview
7.2.3 Eyetech Inc. Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.2.4 Eyetech Inc. Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.2.5 Eyetech Inc. Key News & Latest Developments
7.3 Becton, Dickinson and Company
7.3.1 Becton, Dickinson and Company Company Summary
7.3.2 Becton, Dickinson and Company Business Overview
7.3.3 Becton, Dickinson and Company Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.3.4 Becton, Dickinson and Company Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.3.5 Becton, Dickinson and Company Key News & Latest Developments
7.4 Regeneron Pharmaceuticals, Inc.
7.4.1 Regeneron Pharmaceuticals, Inc. Company Summary
7.4.2 Regeneron Pharmaceuticals, Inc. Business Overview
7.4.3 Regeneron Pharmaceuticals, Inc. Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.4.4 Regeneron Pharmaceuticals, Inc. Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.4.5 Regeneron Pharmaceuticals, Inc. Key News & Latest Developments
7.5 Genentech, Inc.
7.5.1 Genentech, Inc. Company Summary
7.5.2 Genentech, Inc. Business Overview
7.5.3 Genentech, Inc. Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.5.4 Genentech, Inc. Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.5.5 Genentech, Inc. Key News & Latest Developments
7.6 Novartis AG
7.6.1 Novartis AG Company Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.6.4 Novartis AG Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.6.5 Novartis AG Key News & Latest Developments
7.7 Allergan plc
7.7.1 Allergan plc Company Summary
7.7.2 Allergan plc Business Overview
7.7.3 Allergan plc Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.7.4 Allergan plc Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.7.5 Allergan plc Key News & Latest Developments
7.8 Bayer AG
7.8.1 Bayer AG Company Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.8.4 Bayer AG Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.8.5 Bayer AG Key News & Latest Developments
7.9 Santen Pharmaceutical Co., Ltd.
7.9.1 Santen Pharmaceutical Co., Ltd. Company Summary
7.9.2 Santen Pharmaceutical Co., Ltd. Business Overview
7.9.3 Santen Pharmaceutical Co., Ltd. Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.9.4 Santen Pharmaceutical Co., Ltd. Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.9.5 Santen Pharmaceutical Co., Ltd. Key News & Latest Developments
7.10 Shanghai Pharmaceuticals
7.10.1 Shanghai Pharmaceuticals Company Summary
7.10.2 Shanghai Pharmaceuticals Business Overview
7.10.3 Shanghai Pharmaceuticals Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.10.4 Shanghai Pharmaceuticals Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.10.5 Shanghai Pharmaceuticals Key News & Latest Developments
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Company Summary
7.11.2 Johnson & Johnson Anti-angiogenic Ophthalmic Agent Business Overview
7.11.3 Johnson & Johnson Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.11.4 Johnson & Johnson Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.11.5 Johnson & Johnson Key News & Latest Developments
7.12 Pfizer
7.12.1 Pfizer Company Summary
7.12.2 Pfizer Anti-angiogenic Ophthalmic Agent Business Overview
7.12.3 Pfizer Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.12.4 Pfizer Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.12.5 Pfizer Key News & Latest Developments
7.13 Sun Pharma
7.13.1 Sun Pharma Company Summary
7.13.2 Sun Pharma Anti-angiogenic Ophthalmic Agent Business Overview
7.13.3 Sun Pharma Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.13.4 Sun Pharma Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.13.5 Sun Pharma Key News & Latest Developments
7.14 Otsuka Pharmaceutical Co. Ltd
7.14.1 Otsuka Pharmaceutical Co. Ltd Company Summary
7.14.2 Otsuka Pharmaceutical Co. Ltd Business Overview
7.14.3 Otsuka Pharmaceutical Co. Ltd Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.14.4 Otsuka Pharmaceutical Co. Ltd Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.14.5 Otsuka Pharmaceutical Co. Ltd Key News & Latest Developments
7.15 Daiichi Sankyo
7.15.1 Daiichi Sankyo Company Summary
7.15.2 Daiichi Sankyo Business Overview
7.15.3 Daiichi Sankyo Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.15.4 Daiichi Sankyo Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.15.5 Daiichi Sankyo Key News & Latest Developments
7.16 ERC Labs
7.16.1 ERC Labs Company Summary
7.16.2 ERC Labs Business Overview
7.16.3 ERC Labs Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.16.4 ERC Labs Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.16.5 ERC Labs Key News & Latest Developments
7.17 Medicom Health care
7.17.1 Medicom Health care Company Summary
7.17.2 Medicom Health care Business Overview
7.17.3 Medicom Health care Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.17.4 Medicom Health care Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.17.5 Medicom Health care Key News & Latest Developments
7.18 Implant ophthalmic products GmbH
7.18.1 Implant ophthalmic products GmbH Company Summary
7.18.2 Implant ophthalmic products GmbH Business Overview
7.18.3 Implant ophthalmic products GmbH Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.18.4 Implant ophthalmic products GmbH Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.18.5 Implant ophthalmic products GmbH Key News & Latest Developments
7.19 The Geuder Group, MORCHER GmbH
7.19.1 The Geuder Group, MORCHER GmbH Company Summary
7.19.2 The Geuder Group, MORCHER GmbH Business Overview
7.19.3 The Geuder Group, MORCHER GmbH Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.19.4 The Geuder Group, MORCHER GmbH Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.19.5 The Geuder Group, MORCHER GmbH Key News & Latest Developments
7.20 Novamedika
7.20.1 Novamedika Company Summary
7.20.2 Novamedika Business Overview
7.20.3 Novamedika Anti-angiogenic Ophthalmic Agent Major Product Offerings
7.20.4 Novamedika Anti-angiogenic Ophthalmic Agent Sales and Revenue in Global (2018-2023)
7.20.5 Novamedika Key News & Latest Developments
8 Global Anti-angiogenic Ophthalmic Agent Production Capacity, Analysis
8.1 Global Anti-angiogenic Ophthalmic Agent Production Capacity, 2018-2029
8.2 Anti-angiogenic Ophthalmic Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-angiogenic Ophthalmic Agent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-angiogenic Ophthalmic Agent Supply Chain Analysis
10.1 Anti-angiogenic Ophthalmic Agent Industry Value Chain
10.2 Anti-angiogenic Ophthalmic Agent Upstream Market
10.3 Anti-angiogenic Ophthalmic Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-angiogenic Ophthalmic Agent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
